GlassScriptPhysician profile
Jesus Flores
NPI 1417184557
$9,206.42
in general payments reported to CMS, 2019-2025
31 companies · $557 in 2025
The $557 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,562 · 2020: $516 · 2021: $1,152 · 2022: $121 · 2023: $218 · 2024: $81.40 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468 · Travel and Lodging: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.13 |
| Travel and Lodging | $387.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,422.74 | 2019-2021 | |
| Allergan, INC. | $1,865.37 | 2019-2020 | |
| Applied Medical Resources Corporation | $1,027.07 | 2019 | |
| Stryker Corporation | $744.59 | 2019-2021 | |
| Thd America, INC. | $639.56 | 2020-2025 | |
| Tei Biosciences INC | $552.36 | 2019 | |
| Integra Lifesciences Corporation | $408.50 | 2019 | |
| Merck Sharp & Dohme LLC | $362.94 | 2019-2021 | |
| Axonics, INC. | $158.48 | 2022-2024 | Axonics |
| Pacira Pharmaceuticals Incorporated | $137.67 | 2019-2020 | |
| Convatec INC. | $121.20 | 2023 | |
| W. L. Gore & Associates, INC. | $119.22 | 2025 | Gore Tag Conformable Thoracic Endoprosthesis |
| Sirtex Medical INC | $116.34 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $80.66 | 2021-2023 | Gattex |
| Baudax Bio INC. | $60.04 | 2020-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $44.68 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Biom'Up France Sas | $44.34 | 2020 | |
| Davol INC. | $38.82 | 2021-2024 | Arista Ah Flexitip |
| Acera Surgical, INC. | $37.88 | 2019 | |
| Innovation Technologies INC | $31.53 | 2023 | Irrisept |
| Myriad Genetic Laboratories, INC. | $25.99 | 2025 | Myrisk |
| Levita Magnetics International Corp | $19.97 | 2019 | |
| Baxter Healthcare | $18.02 | 2020 | |
| Tela Bio, INC. | $17.81 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.67 | 2024 | Xifaxan |
| Smith+Nephew, INC. | $17.59 | 2020 | |
| Ethicon US, LLC | $17.21 | 2021 | |
| Cook Medical LLC | $15.09 | 2019 | |
| Acell, INC. | $14.49 | 2020 | |
| Shire North American Group INC | $14.45 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesus Flores listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.